Effect of adding leukotriene modifier or salmeterol to inhaled corticosteroids on outcomes: Confounding factor in assessing effectiveness
Don A. Bukstein(Institute for Asthma and Allergy), Allan T. Luskin(Dean Health Systems), Henry J. Henk(Rutgers, The State University of New Jersey)
Cited by 1
Related Papers
Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study
|The Journal of Allergy and Clinical Immunology In Practice|2018|277
The economic impact of allergic rhinitis and current guidelines for treatment
|Annals of Allergy Asthma & Immunology|2011|268
Shared decision making for the allergist
|Annals of Allergy Asthma & Immunology|2018|119
The Challenges and Opportunities for Shared Decision Making Highlighted by COVID-19
|The Journal of Allergy and Clinical Immunology In Practice|2020|119
Digital Health Technology in Asthma: A Comprehensive Scoping Review
|The Journal of Allergy and Clinical Immunology In Practice|2021|119